Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus

In Russia, sulfonylurea drugs are extensively prescribed to patients with type 2 diabetes mellitus. This work was designed to study pharmacoeconomicaspects of application of 2nd generation sulfonylureas based on the results of the GUIDE study comparing effects of therapy with gliclazide modifiedrele...

Full description

Saved in:

Bibliographic Details
Main Author:	Alla Vsevolodovna Rudakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2011-09-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus sulfonylureas hypoglycemia cost-effectiveness analysis
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6234
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
by: Aleksey Vadimovich Zilov, et al.
Published: (2010-06-01)

Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
by: Lyudmila Viktorovna Nedosugova
Published: (2013-06-01)

Feasibility of efficacious therapy of diabetes mellitus by sulfonylurea agents in neonates with KCNJII gene mutation: originalobservation
by: Andrey Olegovich Emel'yanov, et al.
Published: (2009-09-01)

The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus
by: N. A. Petunina, et al.
Published: (2024-09-01)

Systematic Review of Cardiovascular Outcomes with Sulfonylureas, GLP-1 RA, and DPP-4 Inhibitors in Type 2 Diabetes Mellitus
by: Koo Thai Hau, et al.
Published: (2024-07-01)

Type 2 diabetes therapy at the time of diagnosis. Glimepiride: property, efficiency, safety
by: Olga Mikhailovna Smirnova
Published: (2009-03-01)

Relationship between the efficacy of sulfonylurea therapy and structural variants of the ABCC8 (rs757110) and KCNJ11 (rs5219) genes in patients with type 2 diabetes mellitus with different phenotypes
by: I. А. Bondar’, et al.
Published: (2024-04-01)

Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort’s analysis
by: Mansour Bahardoust, et al.
Published: (2025-01-01)

Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis
by: Mansour Bahardoust, et al.
Published: (2025-03-01)

Initiation of insulin therapy in patients with type 2 diabetes: An observational study
by: Zerovnik Spela, et al.
Published: (2022-03-01)

MODY3 in the child with type 2 diabetes mellitus phenotype: case report
by: Tamara Leonidovna Kuraeva, et al.
Published: (2013-06-01)

Hypoglycemia in type 2 diabetes mellitus patients — cerebral, cognitive, psychosocial and clinical aspects
by: K. V. Antonova, et al.
Published: (2022-07-01)

Using Pharmacoepidemiology to Examine the Interplay of Sulfonylureas and Infection Risk in Patients With Diabetes Mellitus
by: Yu‐ying Wu, et al.
Published: (2025-04-01)

Clinical and psychological aspects of hypoglycemia in patients with diabetes mellitus
by: Olga Georgievna Mel'nikova, et al.
Published: (2010-09-01)

Case Report: Beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapy
by: Chiara Gulisano, et al.
Published: (2025-05-01)

Risk of oncological diseases in patients with diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2009-12-01)

The impact of sulfonylureas on diverse ion channels: an alternative explanation for the antidiabetic actions
by: Xian-Tao Li, et al.
Published: (2025-06-01)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
by: Tatiana Ivanovna Romantsova, et al.
Published: (2010-03-01)

A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
by: Yury Shavkatovich Khalimov, et al.
Published: (2011-06-01)

The Effect of Family Caregiver Empowerment Model Intervention on Fear of Hypoglycemia in People with Type-2 Diabetes Mellitus
by: Rondhianto Rondhianto, et al.
Published: (2024-08-01)

The use of long-acting insulin degludec in adult patients with type 2 diabetes mellitus in real clinical practice in Russia
by: G. R. Galstyan
Published: (2023-02-01)

Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up
by: Maja D Ješić, et al.
Published: (2021-06-01)

Hyponatremia as acute adrenal insufficiency in patients with type 1 diabetes mellitus and kidney transplantation cause end-stage chronic kidney disease
by: I. S. Khagabanova, et al.
Published: (2024-07-01)

Sequential development of hyperinsulinemic hypoglycemia and type 1 diabetes mellitus in a male child with trisomy 13
by: Satoru Sugimoto, et al.
Published: (2025-04-01)

The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
by: Tat'yana Ivanovna Ionova, et al.
Published: (2015-12-01)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
by: Tatiana Evgen'evna Taranushenko, et al.
Published: (2012-12-01)

REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY"
by: A. A. Aleksandrov
Published: (2016-01-01)

Hypoglycemic episodes exacerbate skeletal muscle insulin resistance in type 2 diabetes mellitus
by: Hendra Zufry, et al.
Published: (2025-04-01)

Pharmacoepidemiological and pharmacoeconomic analyses of the utilization of hypoglycaemic drugs in patients with type 2 diabetes mellitus in Moscow
by: Marina Fedorovna Kalashnikova, et al.
Published: (2015-06-01)

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
by: Vladimir Ivanovich Kudinov, et al.
Published: (2012-06-01)

Diagnosis and Treatment of Neonatal Diabetes Caused by ATP-Channel Mutations: Genetic Insights, Sulfonylurea Therapy, and Future Directions
by: Michela Trada, et al.
Published: (2025-02-01)

Pharmacoeconomic aspects of the treatment of diabetic foot syndrome
by: Marina Fedorovna Kalashnikova, et al.
Published: (2010-06-01)

THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS: RISKS AND PROSPECTS
by: L. Yu. Morgunov
Published: (2017-12-01)

Features of management and treatment of elderly patients with type 2 diabetes mellitus
by: L. Yu. Morgunov, et al.
Published: (2022-10-01)

Glibenclamide - profile of efficacy and safety
by: Lyudmila Viktorovna Nedosugova
Published: (2011-09-01)

Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
by: Marina Vladimirovna Shestakova, et al.
Published: (2015-12-01)

Similarity of the gastrointestinal mechanisms underlying the development of osteoporosis and diabetes mellitus
by: Elena V. Doskina
Published: (2024-10-01)

Prevalence of hypoglycemic conditions in adolescents with type 1 diabetes mellitus in real clinical practice
by: I. M. Tsargasova, et al.
Published: (2023-01-01)

Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning
by: Motahare Shabestari, et al.
Published: (2025-05-01)

Sulfonylureas in the modern strategy of therapy of type 2 diabetes
by: Lyudmila Viktorovna Nedosugova
Published: (2011-06-01)